FGF23 and chronic kidney disease: Collectively, these data support that FGF23 may provide protective effects for bone with changes in iron utilization during CKD, or that the combination of supraphysiological serum phosphate plus an increase of serum iron altered skeletal properties, and that FC did not significantly influence mineral or matrix quality.